"Carcinoma, Large Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A tumor of undifferentiated (anaplastic) cells of large size. It is usually bronchogenic. (From Dorland, 27th ed)
| Descriptor ID |
D018287
|
| MeSH Number(s) |
C04.557.470.200.260
|
| Concept/Terms |
Carcinoma, Large Cell- Carcinoma, Large Cell
- Carcinomas, Large Cell
- Cell Carcinoma, Large
- Cell Carcinomas, Large
- Large Cell Carcinoma
- Large Cell Carcinomas
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Large Cell".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Large Cell".
This graph shows the total number of publications written about "Carcinoma, Large Cell" by people in this website by year, and whether "Carcinoma, Large Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 1 | 2 |
| 2007 | 0 | 1 | 1 |
| 2009 | 0 | 2 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2018 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Large Cell" by people in Profiles.
-
The serum-based VeriStrat? test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients. BMC Cancer. 2018 03 20; 18(1):310.
-
Progress in the Treatment and Outcomes for Early-Stage Non-Small Cell Lung Cancer. Lung. 2018 06; 196(3):351-358.
-
Patterns of locoregional failure in stage III non-small cell lung cancer treated with definitive chemoradiation therapy. Pract Radiat Oncol. 2014 Sep-Oct; 4(5):342-348.
-
Randomized phase II study of cetuximab and bevacizumab in combination with two regimens of paclitaxel and carboplatin in chemonaive patients with stage IIIB/IV non-small-cell lung cancer. J Thorac Oncol. 2013 Mar; 8(3):338-45.
-
Intraoperative sentinel node mapping with technitium-99 in lung cancer: results of CALGB 140203 multicenter phase II trial. J Thorac Oncol. 2009 Feb; 4(2):198-202.
-
Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC). J Thorac Oncol. 2009 Jan; 4(1):12-21.
-
Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer. J Clin Oncol. 2007 Oct 20; 25(30):4743-50.
-
Lymph node metastasis of large-cell carcinoma of the lung in a seventeen-year-old patient: diagnosis by fine-needle aspiration. Diagn Cytopathol. 2006 Dec; 34(12):852-3.
-
Administration of pemetrexed immediately following gemcitabine as front-line therapy in advanced non-small cell lung cancer: a phase II trial. Lung Cancer. 2006 Jul; 53(1):77-83.
-
Epithelial tumors of the lung. Chest Surg Clin N Am. 2000 Nov; 10(4):709-28.